The global Collagen and Gelatin Market in terms of revenue was estimated to be worth $1.2 billion in 2023 and is poised to reach $1.6 billion by 2028, growing at a CAGR of 6.5% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The rising incidence of chronic diseases, increasing demand for collagen and gelatin due to increased demand for wound care products, and strong emphasis on the launch of novel products by key market players are driving the market growth.
Key players in the Collagen and Gelatin market include Integra LifeSciences (US), DSM (Netherlands), CollPlant Biotechnologies Ltd. (Israel), Nitta Gelatin Inc. (Japan), Collagen Solutions PLC (UK), and others.
Download a FREE Sample Report PDF of the Global Collagen and Gelatin Market Research Report at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95663122&utm_source=Ganesh&utm_medium=P
The orthopedic segment dominated the collagen and gelatin industry in 2022.
Based on application, the global collagen and gelatin market is segmented into wound care, dental, orthopedic, surgical, cardiovascular, and other collagen applications. The global gelatin market is segmented into orthopedics, wound care, and other gelatin application. The orthopedic segment accounted for the largest share of the both market. The dominant share is majorly due to the rising adoption of biomaterials in orthopedic surgeries and the launch of novel products in the market.
The hospitals segment of collagen and gelatin industry accounted for the segment-dominated market in 2022.
Based on end users, the collagen and gelatin market is segmented into hospitals and surgical centers. In 2022, the hospitals segment accounted for the largest share of the market. The segment held the dominant share in the market owing to various factors such as an increased number of surgical procedures across the globe and increased adoption of collagen-based products in orthopedic, wound care, dental and other applications.
North America held a dominant share in the regional market for the collagen and gelatin industry in 2022.
Geographically, the collagen and gelatin market is segmented into North America, Europe, Asia Pacific, Rest of the World. In 2022, North America accounted for the largest share of the gelatin market, followed by Europe & Asia Pacific. The dominance of the region is attributable to various factors, such as the presence of top market players in the region, the presence of top medical facilities leading to the adoption of technologically advanced wound care products, and the increased number of surgeries in the region.
This report categorizes the collagen and gelatin market to forecast revenue and analyze trends in each of the following submarkets:
By Source
- Bovine
- Porcine
- Other sources
By Application
- Orthopedic
- Wound Care
- Dental
- Surgical
- Cardiovascular Disease
- Others
By Application
- Orthopedic
- Wound Care
- Other Applications
By End User
- Hospitals
- Surgical Centers
By Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Rest of Europe (RoE)
- Asia Pacific (APAC)
- Japan
- China
- India
- Rest of Asia Pacific (RoAPAC)
- Rest of World (RoW)
- Latin America
- Middle East and Africa (MEA)
Direct Purchase of the Global Collagen and Gelatin Market Research Report at https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=95663122&utm_source=Ganesh&utm_medium=P
Recent Developments of Collagen and Gelatin Industry
- In January 2023, TELA Bio, Inc. launched NIVIS Fibrillar Collagen Pack. NIVIS Fibrillar Collagen Pack is an absorbent matrix of Type I and Type III bovine collagen proposed to manage moderately to heavily exudating wounds and to control minor bleeding.
- In October 2022, Collagen Matrix acquired Polyganics B.V. expanded its portfolio of bioresorbable solutions and technology platforms for bone and tissue repair.
- In January 2021, Integra LifeSciences acquired ACell. This acquisition enabled the company to provide more comprehensive complex wound management solutions.
